Navigation Links
Colorectal Cancer Treatment Costs Vary Widely
Date:11/20/2008

Chemotherapy figures alone may differ by almost $37,000 per patient, study finds

THURSDAY, Nov. 20 (HealthDay News) -- The cost of treating colorectal cancer can vary by tens of thousands of dollars per patient.

To reach that conclusion, researchers compared the eight most commonly prescribed therapeutic regimens used to treat more than 400 patients at 115 ambulatory care centers across the United States.

The regimens, which included supportive agents often required to ease treatment-related side effects such as nausea, ranged from the older chemotherapy cocktail 5-FU/LV (5-fluoroucil and leucovorin calcium) to newer therapies that include bevacizumab (brand name Avastin), which choke off a tumor's blood supply.

"The total cost of chemotherapy to treat colorectal cancer may differ by as much as $36,999 per patient, depending on the regimen," study senior investigator Dr. Gary Lyman, an oncologist and health outcomes researcher at the Duke Comprehensive Cancer Center, said in a Duke news release. "We know that some therapies are more promising and effective, in general, than others, and cost variation raises many questions about what kind of care patients are receiving and whether this economic burden is matched by significant clinical advancements, especially with regard to quality of life."

The study was published in the November issue of the American Journal of Managed Care.

Each year in the United States, almost 150,000 cases of colorectal cancer are diagnosed, and about 56,000 people die of the disease. Colorectal cancer is the third most common kind of cancer in the United States and the second leading cause of cancer death, the researchers said.

"The cost of treating colorectal cancer has skyrocketed. We have seen similar trends in terms of rapidly rising costs of drug development in breast cancer and other malignancies, but nowhere has this been more striking than in the management of colorectal cancer," Lyman said.

Life-extending therapies introduced over the past several years can almost double survival time in some cases and have led to a 340 percent increase in chemotherapy costs for colorectal cancer treatment, the study found.

"For many of these colorectal cancer patients, depending on how advanced their disease is, we may be talking about buying a few months. And these rapidly increasing costs have raised ethical questions about whether such sums of money should be dedicated to treatments that may modestly prolong life but not offer increased cure rate," Lyman said.

He added that the study findings suggest new strategies may be necessary to limit the economic impact of newer colorectal cancer therapies, such as easing restrictions on the federal government's ability to negotiate drug prices and asking drug makers to reassess their pricing policies.

More information

The U.S. National Cancer Institute has more about colorectal cancer treatment.



-- Robert Preidt



SOURCE: Duke Medicine, news release, Nov. 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Calcium may only protect against colorectal cancer in presence of magnesium
2. Cost of treating colorectal cancer can vary by thousands per patient
3. Lazarex Cancer Foundation Sponsors Community Colorectal Cancer Screening at Alta Bates Summit Medical Center
4. Get Screened Video Contest Throws a Spotlight on the Importance of Colorectal-Cancer Screening
5. National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography
6. DNA Direct Announces Availability of ColoSure(TM) Colorectal Cancer Screening Test
7. LOH analysis on 4q in sporadic colorectal carcinoma
8. Risk of colorectal cancer extremely low 5 years after a normal colonoscopy screening
9. UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics
10. Many colorectal cancer survivors do not receive recommended follow-up care
11. National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry:
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Colorectal Cancer Treatment Costs Vary Widely
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology: